Analysen von Michael Leuchten
| 03.02.21 | Novo Nordisk Neutral | UBS AG | |
| 28.01.21 | Sartorius vz. Sell | UBS AG | |
| 26.01.21 | AstraZeneca Neutral | UBS AG | |
| 21.01.21 | Merck Neutral | UBS AG | |
| 14.01.21 | AstraZeneca Neutral | UBS AG | |
| 12.01.21 | Roche buy | UBS AG | |
| 17.12.20 | Novo Nordisk Neutral | UBS AG | |
| 14.12.20 | AstraZeneca Neutral | UBS AG | |
|
Werbung
|
|||
| 09.12.20 | AstraZeneca Neutral | UBS AG | |
| 30.11.20 | AstraZeneca Neutral | UBS AG | |
| 23.11.20 | AstraZeneca Sell | UBS AG | |
| 17.11.20 | Merck Neutral | UBS AG | |
| 12.11.20 | Merck Neutral | UBS AG | |
| 10.11.20 | Roche buy | UBS AG | |
| 09.11.20 | Novo Nordisk Neutral | UBS AG | |
| 09.11.20 | Sartorius vz. Sell | UBS AG | |
| 05.11.20 | AstraZeneca Sell | UBS AG | |
| 03.11.20 | Bayer buy | UBS AG | |
| 02.11.20 | Novo Nordisk Neutral | UBS AG | |
| 30.10.20 | Novo Nordisk Neutral | UBS AG | |
| 29.10.20 | Roche buy | UBS AG | |
| 26.10.20 | AstraZeneca Sell | UBS AG | |
| 26.10.20 | Bayer buy | UBS AG | |
| 16.10.20 | Roche buy | UBS AG | |
| 15.10.20 | Roche buy | UBS AG | |
| 14.10.20 | Bayer buy | UBS AG | |
| 09.10.20 | Novo Nordisk Neutral | UBS AG | |
| 05.10.20 | Bayer buy | UBS AG | |
| 01.10.20 | Bayer buy | UBS AG | |
| 30.09.20 | Roche buy | UBS AG | |
| 25.09.20 | Novo Nordisk Neutral | UBS AG | |
| 18.09.20 | Roche buy | UBS AG | |
| 09.09.20 | AstraZeneca Sell | UBS AG | |
| 02.09.20 | Roche buy | UBS AG | |
| 18.08.20 | Novo Nordisk Neutral | UBS AG | |
| 11.08.20 | Roche buy | UBS AG | |
| 07.08.20 | Merck Neutral | UBS AG | |
| 06.08.20 | Novo Nordisk Neutral | UBS AG | |
| 04.08.20 | Bayer buy | UBS AG | |
| 31.07.20 | Sartorius vz. Sell | UBS AG | |
| 30.07.20 | Roche buy | UBS AG | |
| 27.07.20 | Roche buy | UBS AG | |
| 23.07.20 | Roche buy | UBS AG | |
| 22.07.20 | Bayer buy | UBS AG | |
| 21.07.20 | Sartorius vz. Sell | UBS AG | |
| 21.07.20 | AstraZeneca Sell | UBS AG | |
| 20.07.20 | Novo Nordisk Neutral | UBS AG | |
| 16.07.20 | Sartorius vz. Sell | UBS AG | |
| 10.07.20 | Bayer buy | UBS AG | |
| 09.07.20 | Bayer buy | UBS AG | |